Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment.
about
From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic CancersPolymorphisms and expression pattern of circular RNA circ-ITCH contributes to the carcinogenesis of hepatocellular carcinoma.FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib.Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short report.Emerging role of precision medicine in biliary tract cancersFGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis
P2860
Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased FGF19 copy number is ...... nse after sorafenib treatment.
@en
Increased FGF19 copy number is ...... nse after sorafenib treatment.
@nl
type
label
Increased FGF19 copy number is ...... nse after sorafenib treatment.
@en
Increased FGF19 copy number is ...... nse after sorafenib treatment.
@nl
prefLabel
Increased FGF19 copy number is ...... nse after sorafenib treatment.
@en
Increased FGF19 copy number is ...... nse after sorafenib treatment.
@nl
P2093
P2860
P356
P1433
P1476
Increased FGF19 copy number is ...... onse after sorafenib treatment
@en
P2093
A-Hon Kwon
Akishige Kanazawa
Hideyuki Matsushima
Hiroaki Kitade
Hiroaki Nagano
Hiroshi Wada
Hiroya Iida
Kazuko Sakai
Kazuto Nishio
Kosuke Matsui
P2860
P304
49091-49098
P356
10.18632/ONCOTARGET.10077
P407
P577
2016-08-01T00:00:00Z